FindTrial
Sign In

Adrenocorticotropic Hormone

DRUG5 trials

Sponsors

State University of New York at Buffalo, Johns Hopkins University, Chongqing Medical University, Shanghai 10th People's Hospital, Astellas Pharma Global Development, Inc.

Conditions

GoutMetastatic Castration-Resistant Prostate CancerMetastatic Hormone Sensitive Prostate CancerMultiple SclerosisPrimary AldosteronismProliferative VitreoretinopathyProstate Cancer

Early Phase 1

Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)
CompletedNCT03727776
Johns Hopkins UniversityProliferative Vitreoretinopathy
Start: 2019-08-19End: 2023-07-07Updated: 2023-08-08

Phase 2

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
RecruitingNCT07005154
Astellas Pharma Global Development, Inc.Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer, Prostate Cancer
Start: 2025-06-19End: 2032-05-31Target: 218Updated: 2026-04-02

Phase 3

Effects of Acthar on Recovery From Cognitive Relapses in MS
CompletedNCT02290444
State University of New York at BuffaloMultiple Sclerosis
Start: 2013-08-31End: 2018-11-01Updated: 2020-04-06

Unknown Phase

Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism(ADOPA)
CompletedNCT04461535
Chongqing Medical UniversityPrimary Aldosteronism
Start: 2020-07-08End: 2023-02-20Updated: 2023-12-29
Treatment of Refractory Gout With ACTH or Methylprednisolone
NCT04808856
Shanghai 10th People's HospitalGout
Start: 2021-04-01End: 2022-04-01Target: 60Updated: 2021-03-22

Related Papers

Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism
JAMA Network Open2023-10-2319 citations